back to Australia directory
australia clinical guidance

Anaemia: vitamin B12 and folate deficiency

A detailed Australian summary of anaemia: vitamin b12 and folate deficiency, with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team · Clinical editorial review · reviewed 2026-08-20 · due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Confirm deficiency with blood count, film and appropriate B12 or folate tests, interpreting borderline results with symptoms, medicines and laboratory limitations. Look for dietary restriction, pernicious anaemia, gastric or ileal disease, surgery, nitrous oxide, metformin, acid suppression and alcohol. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:Australian Prescriber vitamin B12

The Bottom Line

  • Confirm deficiency with blood count, film and appropriate B12 or folate tests, interpreting borderline results with symptoms, medicines and laboratory limitations.
  • Look for dietary restriction, pernicious anaemia, gastric or ileal disease, surgery, nitrous oxide, metformin, acid suppression and alcohol.
  • Neurological B12 deficiency can occur without macrocytosis or anaemia and treatment should not await haematological change.
  • Treat suspected B12 deficiency promptly when neurological features are present and do not give folate alone before excluding B12 deficiency.
sources for this section:Australian Prescriber vitamin B12

Practical clinical workflow

1

Topic-specific assessment action

Confirm deficiency with blood count, film and appropriate B12 or folate tests, interpreting borderline results with symptoms, medicines and laboratory limitations.
2

Topic-specific diagnostic action

Treat suspected B12 deficiency promptly when neurological features are present and do not give folate alone before excluding B12 deficiency.
3

Topic-specific management action

Choose replacement route and duration by cause and absorption, and monitor haematological and neurological response while addressing the underlying condition.
4

Topic-specific follow-through

Pernicious anaemia implies lifelong replacement and associated autoimmune and gastric-risk considerations.
sources for this section:Australian Prescriber vitamin B12

Safety boundaries and escalation

  • Severe anaemia symptoms, pancytopenia, progressive neuropathy, gait change, cognitive deterioration or diagnostic uncertainty requires urgent specialist review.
  • Nitrous oxide exposure can inactivate B12 and produce functional deficiency even when a serum concentration appears borderline.
sources for this section:Australian Prescriber vitamin B12

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO–RACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:Australian Prescriber vitamin B12

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:Australian Prescriber vitamin B12

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Australian Prescriber, Australian Government Department of Health, Disability and AgeingVitamin B12 deficiency: testing and treatmentDOI 10.18773/austprescr.2026.012 · Australian Prescriber 2026;49:55–60, published 7 April 2026 · accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.